Interestingly, in cancers of the breast, the expression of this splice variant is seemingly advantageous as MUC1/Y is apparently found to be present in malignant tissue yet undetectable in neighbouring normal tissue of the same organ, thus establishing MUC1/Y as a potential marker for identifying malignancy [6,9]. Here, MUC1 is linked to breast cancer.